Key result
Dichloroacetate increased PDHC activity by 76% but did not reduce myocardial infarct size vs control.
Answers are grounded in this paper and cite their sources.
Demonstrates that dichloroacetate lowers plasma lactate but fails to reduce myocardial infarct size in rabbits, indicating metabolic activation does not prevent tissue death.
Dichloroacetate (DCA), an activator of pyruvate dehydrogenase (PDHC), enhances postischemic mechanical recovery of isolated hearts. It is not known whether this is secondary to reduced infarction or preservation of contractile function in viable cardiomyocytes. This study investigated the effect of DCA on myocardial infarct size. Anesthetized open chest rabbits underwent regional coronary occlusion and reperfusion. DCA (300 mg/kg plus 150 mg/kg 1 h later) was administered intravenously either before occlusion (DCA-O; n = 8) or at reperfusion (DCA-R; n = 7). Control rabbits (n = 8) received saline vehicle. Myocardial PDHC activity was measured after administration of 300 mg/kg i.v. DCA in 10 separate rabbits. DCA reduced plasma lactate levels and increased PDHC activity by 76%, from 2.79 +/- .30 mumol/min.g-1 to 4.92 +/- .44 mumol/min.g-1 (p < .005). However, infarct size in DCA-treated animals was not significantly different from Control (60 +/- 5% DCA-O, 57 +/- 6% DCA-R, 58 +/- 7% Control). We conclude that stimulation of pyruvate dehydrogenase does not limit infarct size.
No takes yet. Share an insight, caveat, or question.
Haessler et al. (1996) studied Myocardial ischemia and reperfusion (experimental rabbit model) (n=33). Dichloroacetate (DCA) vs. Saline vehicle was evaluated on Myocardial infarct size. Dichloroacetate increased PDHC activity by 76% but did not reduce myocardial infarct size vs control.
Synapse has enriched 10 related papers. Consider them for comparative context: